With in vitro diagnostics (IVD)s becoming more important for drug development ... much promise, pharmaceutical companies can’t ignore the role of diagnostics in their future strategies, whether ...

Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Too often, the disconnect between a company’s IT department and its business teams slows progress and leads to missed ...

The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs ...

“It’s like, in some way, searching for a needle in a haystack,” said Aviv Regev, Genentech’s executive vice president for ...

at seven National Institutes of Pharmaceutical Education and Research (NIPERs). This will focus on anti-viral and anti- bacterial drug discovery and development, medical devices, bulk drugs ...